NLRP3 and type 2 diabetes mellitus: It is proved that NLRP3 inflammasome mediated several inflammatory diseases including type 2 diabetes (Masters et al., 2010), inflammatory bowel disease (Cocco et al., 2017) and neurodegenerative diseases (Heneka et al., 2013).